查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600611

临床试验供应和物流市场：按服务、按类型、按阶段、按治疗领域、按最终用户 - 2025-2030 年全球预测

Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年临床试验用品和物流市场的市场规模为243.3亿美元，预计2024年将达到262亿美元，复合年增长率为7.75%，预计到2030年将达到410.4亿美元。

临床试验供应和物流市场对于临床试验顺利、有效率地发展至关重要。该市场包括临床研究和临床试验所需的药品和医疗材料的供应链管理、仓储、配送和运输。临床试验中对高效物流和供应链的需求主要源自于需要遵守严格的监管标准、维持药物完整性以及及时交付至研究机构。该应用程式对于管理跨多个地区的广泛临床试验的製药公司和委外研发机构(CRO) 至关重要。该应用的最终用途范围从製药和生物技术公司到 CRO，甚至是专门从事医疗保健的物流服务提供者。

主要市场统计
基准年[2023] 243.3亿美元
预测年份 [2024] 262亿美元
预测年份 [2030] 410.4亿美元
复合年增长率（%） 7.75%

关键的成长要素包括临床试验数量的增加，特别是随着个人化医疗和生技药品的兴起，以及试验扩展到新兴市场。温控包装和即时追踪系统等先进技术的采用正在扩大简化供应链和减少产品浪费的机会。区块链等创新透过人工智慧和机器学习进行预测分析来提高透明度和自动化，具有巨大的潜力。然而，市场也面临复杂的监管环境、高营运成本以及与低温运输管理相关的物流困难等挑战。

随着患者数量的增加和监管改革的进展，我们有潜力扩大我们的区域业务，特别是在亚太和拉丁美洲。此外，还有一些领域需要创新，例如改善低温运输物流、提高物联网设备的可见度以及利用资料分析主动管理风险。总之，虽然临床试验供应和物流市场存在巨大的成长机会，但必须克服成本压力和监管挑​​战等限制。寻求创新和利用这些机会的公司应该投资于技术和策略伙伴关係，以确保他们能够提供适合临床试验不断发展的性质的高效物流解决方案。

市场动态：揭示快速发展的临床试验供应和物流市场的关键市场洞察

供需的动态交互作用正在改变临床试验供应和物流市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 增加政府资金，以加强慢性病盛行率上升的经济体的药物研发活动。
    • 临床试验的全球化与法规的统一
  • 市场限制因素
    • 技术整合和资料管理问题
  • 市场机会
    • 整合人工智慧和机器学习以进行供应链优化中的预测分析
    • 药厂和 CDMO 之间的伙伴关係活动增加
  • 市场挑战
    • 临床试验供应和物流的业务问题

波特五力：驾驭临床试验供应与物流市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解临床试验供应和物流市场的外部影响

外部宏观环境因素在塑造临床试验供应和物流市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解临床试验用品和物流市场的竞争格局

对临床试验用品和物流市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵临床试验供应与物流市场供应商的绩效评估

FPNV 定位矩阵是评估临床试验供应和物流市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着慢性病发病率上升，政府增加资金以加强整个经济中的药物研发活动
      • 临床试验的全球化与法规的统一
    • 抑制因素
      • 与技术整合和资料管理相关的问题
    • 机会
      • 整合人工智慧和机器学习以进行供应链优化中的预测分析
      • 药厂和 CDMO 之间的合作活动增加
    • 任务
      • 与临床试验供应和物流业务相关的担忧
  • 市场区隔分析
    • 服务：低温运输配送服务随着需求的成长而不断发展
    • 类型：小分子在医药领域的使用快速增加
    • 阶段：扩大3期临床试验供应与物流服务范围
    • 治疗领域：私营和公共部门在肿瘤学方面的投资和研究活动激增
    • 最终用户：製药和生物技术公司更多地使用临床试验用品和物流
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化
    • Catalent, Inc.：积极参与网路研讨会和会议，推广临床试验供应和物流方面的创新解决方案和服务。
    • Infosys Limited：专注渗透定价策略，以低价提供解决方案，同时确保高精度和高品质
    • Almac 集团：Marken 发起新的行销宣传活动以促进临床药品的储存和分销
    • Eurofins Scientific Group：Eurofins Scientific Group 专注于会议和展览，以实现有效的产品行销。
    • Lonza Group AG：Lonza Group AG 加强全球扩张的关键数位行销策略
    • 生物药品：利用数位技术简化供应链、提高透明度并改善与相关人员的沟通
    • 医疗设备：传播解决相关人员担忧的教育内容
    • 小分子：解决激烈竞争和监管复杂性的需要
    • 临床试验供应及物流服务采取多元化行销策略

第六章临床试验供应与物流市场：依服务分类

  • 比较采购
  • 物流/配送
    • 低温运输运输
    • 非低温运输运输
  • 製造业
  • 包装、标籤和致盲
  • 储存和保留

第七章临床试验用品和物流市场：按类型

  • 生物製药
  • 医疗设备
  • 小分子

第八章临床试验供应及物流市场分阶段

  • 学士/工学士研究
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第九章依治疗领域分類的临床试验供应及物流市场

  • 血液疾病
  • 心血管疾病
  • 中枢神经系统和精神障碍
  • 皮肤病
  • 消化系统疾病
  • 耳鼻喉科疾病
  • 免疫学
  • 感染疾病
  • 代谢紊乱
  • 肾臟病学
  • 肿瘤学
  • 罕见疾病
  • 呼吸系统疾病

第10章临床试验供应与物流市场：依最终使用者分类

  • 合约调查机构
  • 医疗设备公司
  • 製药和生物技术公司

第十一章美洲临床试验供应及物流市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太临床试验供应及物流市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲临床试验供应及物流市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • PCM Trials 收购荷兰临床试验服务
    • Piramal Pharma Solutions 庆祝在苏格兰格兰奇茅斯开设 ADC 製造厂
    • Biocare 宣布美国扩张作为全球成长策略的一部分
    • Vaxcyte 与 Lonza 签署新的 PCV 商业製造协议
    • Piramal Pharma Solutions 在艾哈默德巴德的Discovery Services 地点推出体外生物学功能
    • Signant Health 推出 Signant Biotech，以加速和简化新兴生物製药公司的临床开发
    • N-SIDE 推出革命性软体 Lighthouse，塑造全球临床试验供应管理的未来
    • Zuellig Pharma 与 GSK 在新加坡建立疫苗分销中心
    • Alyceum Therapeutics 与 Eurofins CDMO 签署医药多计划协议
    • Vial宣布与皇家国际集团建立策略伙伴关係
    • Biocair 与 TrakCel 合作提高供应链视觉性
    • IDEAYA 扩大与辉瑞的临床试验合作和供应协议
    • 康泰伦特开始斥资 2,000 万美元扩建德国临床供应设施
    • Eurofins Biopharma 产品测试 ENCO 扩大在美国的产能
    • Calyx推出新的临床试验供应预测服务
    • 康泰伦特完成新加坡临床供应设施扩建，以提高温度控制能力
    • PAREXEL 在中国苏州开设临床试验用品和物流仓库

公司名单

  • Acnos Pharma GmbH
  • ADAllen Pharma Ltd
  • Almac Group Limited
  • Ancillare, LP
  • Avantor, Inc.
  • Beroe Holdings Inc.
  • Biocair International Limited
  • Calyx
  • Catalent, Inc.
  • Clinical Services International LTD
  • Clinigen Group PLC
  • COREX LOGISTICS LIMITED
  • DHL Group
  • Eurofins Scientific SE
  • Experic, LLC
  • FedEx Corporation
  • ICON PLC
  • Inceptua SA
  • Infosys Limited
  • IPS Pharma
  • KLIFO A/S
  • Lonza Group AG
  • Marken Limited by United Parcel Service, Inc.
  • Microsoft Corporation
  • Myonex, Inc.
  • N-SIDE SA
  • NUVISAN GmbH
  • OCT Clinical GmbH
  • Octalsoft
  • Parexel International Corporation
  • PCI Pharma Services
  • PHOENIX Pharmahandel GmbH & Co KG
  • Piramal Pharma Limited
  • Recipharm AB
  • SAP SE
  • Sharp Services, LLC
  • Signant Health
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific Inc.
  • Tower Cold Chain Solutions
  • Uniphar PLC
  • Walden Group
  • Zuellig Pharma Pte Ltd by Interpharma Investments Limited
Product Code: MRR-501246436315

The Clinical Trial Supply & Logistics Market was valued at USD 24.33 billion in 2023, expected to reach USD 26.20 billion in 2024, and is projected to grow at a CAGR of 7.75%, to USD 41.04 billion by 2030.

The clinical trial supply and logistics market is critical to ensuring that clinical trials proceed smoothly and efficiently. This market encompasses the supply chain management, warehousing, distribution, and transportation of pharmaceutical goods and medical supplies necessary for clinical research and trials. The necessity for efficient logistics and supply chains in clinical trials primarily stems from the need to adhere to strict regulatory standards, maintain drug integrity, and ensure timely delivery to research sites. This application is vital for pharmaceutical companies and contract research organizations (CROs) that manage extensive trials across multiple geographic regions. Its end-use scope spans pharmaceutical and biotechnology companies, CROs, and even logistics service providers who specialize in healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 24.33 billion
Estimated Year [2024] USD 26.20 billion
Forecast Year [2030] USD 41.04 billion
CAGR (%) 7.75%

Key growth factors include the increasing number of clinical trials, especially with the rise of personalized medicine and biologics, and the expansion of trials into emerging markets. The adoption of advanced technologies like temperature-controlled packaging and real-time tracking systems has opened opportunities to improve supply chain efficiencies and reduce product wastage. Innovations such as Blockchain for enhancing transparency and automation with AI and machine learning for predictive analytics hold much promise. However, the market also faces challenges such as complex regulatory landscapes, high operational costs, and logistical difficulties associated with cold chain management.

Opportunities lie in the expansion of regional presence, especially in Asia-Pacific and Latin America, due to increasing patient pools and favorable regulatory reform. Furthermore, areas ripe for innovation include improving cold chain logistics, enhancing visibility with IoT-enabled devices, and leveraging data analytics for proactive risk management. In conclusion, while the clinical trial supply and logistics market has significant opportunities for growth, overcoming limitations such as cost pressures and regulatory challenges is vital. Companies aiming to innovate and capitalize on these opportunities should invest in technology and strategic partnerships, ensuring they can offer tailored, efficient logistics solutions for the evolving nature of clinical trials.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Supply & Logistics Market

The Clinical Trial Supply & Logistics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
    • Globalization of clinical trials and harmonization of regulations
  • Market Restraints
    • Problems associated with technology integration and data management
  • Market Opportunities
    • Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
    • Increasing partnership activities between pharmaceutical manufacturers and CDMOs
  • Market Challenges
    • Concerns associated with the operations within clinical trial supply and logistics

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Supply & Logistics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Supply & Logistics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Supply & Logistics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Supply & Logistics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Supply & Logistics Market

A detailed market share analysis in the Clinical Trial Supply & Logistics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Supply & Logistics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Supply & Logistics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supply & Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Comparator Sourcing, Logistics & Distribution, Manufacturing, Packaging, Labeling, & Blinding, and Storage & Retention. The Logistics & Distribution is further studied across Cold Chain Distribution and Non-Cold Chain Distribution.
  • Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules.
  • Based on Phase, market is studied across BA/ BE studies, Phase 1, Phase 2, Phase 3, and Phase 4.
  • Based on Therapeutic Area, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Dermatological Disorders, Digestive Disorders, ENT Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Nephrology, Oncology, Rare Diseases, and Respiratory Disorders.
  • Based on End User, market is studied across Contract Research Organisations, Medical Devices Companies, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
      • 5.1.1.2. Globalization of clinical trials and harmonization of regulations
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with technology integration and data management
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
      • 5.1.3.2. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
    • 5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
    • 5.2.3. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
    • 5.2.4. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
    • 5.2.5. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization
    • 5.5.1. Catalent, Inc. : Active participation in webinars and conferences to promote innovative solutions and services in clinical trial supply and logistics
    • 5.5.2. Infosys Limited: Focus on penetration pricing strategy to provide solution at a low price while ensuring high precision and quality
    • 5.5.3. Almac Group: Launch of new marketing campaign by Marken Limited to promote clinical drug product storage and distribution
    • 5.5.4. Eurofins Scientific Group: Eurofins Scientific Group's focus on conferences and fairs for effective product marketing
    • 5.5.5. Lonza Group AG: Significant digital marketing strategies by Lonza Group AG to enhance their global reach
    • 5.5.6. Biologic Drugs: Utilisation of digital technologies to streamline the supply chain, enhance transparency, and improve communication with stakeholders
    • 5.5.7. Medical Devices: Disseminating educational content addressing stakeholders' pain points
    • 5.5.8. Small Molecules: Need to address intense competition and regulatory complexities
    • 5.5.9. Adoption of diverse marketing strategies for clinical trial supply & logistics services

6. Clinical Trial Supply & Logistics Market, by Services

  • 6.1. Introduction
  • 6.2. Comparator Sourcing
  • 6.3. Logistics & Distribution
    • 6.3.1. Cold Chain Distribution
    • 6.3.2. Non-Cold Chain Distribution
  • 6.4. Manufacturing
  • 6.5. Packaging, Labeling, & Blinding
  • 6.6. Storage & Retention

7. Clinical Trial Supply & Logistics Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small Molecules

8. Clinical Trial Supply & Logistics Market, by Phase

  • 8.1. Introduction
  • 8.2. BA/ BE studies
  • 8.3. Phase 1
  • 8.4. Phase 2
  • 8.5. Phase 3
  • 8.6. Phase 4

9. Clinical Trial Supply & Logistics Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Blood Disorders
  • 9.3. Cardiovascular Diseases
  • 9.4. CNS & Mental Disorders
  • 9.5. Dermatological Disorders
  • 9.6. Digestive Disorders
  • 9.7. ENT Diseases
  • 9.8. Immunology
  • 9.9. Infectious Diseases
  • 9.10. Metabolic Disorders
  • 9.11. Nephrology
  • 9.12. Oncology
  • 9.13. Rare Diseases
  • 9.14. Respiratory Disorders

10. Clinical Trial Supply & Logistics Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Medical Devices Companies
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supply & Logistics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supply & Logistics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. PCM Trials acquires Netherlands-based Clinical Trial Service
    • 14.3.2. Piramal Pharma Solutions Commemorates Opening of its ADC Manufacturing Expansion in Grangemouth, Scotland
    • 14.3.3. Biocair Announces the U.S. Expansion as Part Of Global Growth Strategy
    • 14.3.4. Vaxcyte and Lonza Sign New Commercial Manufacturing Agreement for PCVs
    • 14.3.5. Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
    • 14.3.6. Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organizations
    • 14.3.7. N-SIDE Introduces Lighthouse, Innovative Software to Shape the Future of Worldwide Clinical Trial Supply Management
    • 14.3.8. Zuellig Pharma and GSK establish vaccine distribution hub in Singapore
    • 14.3.9. Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
    • 14.3.10. Vial Announces Strategic Partnership with Royale International Group
    • 14.3.11. Biocair Partners with TrakCel to Improve Visibility in the Supply Chain
    • 14.3.12. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
    • 14.3.13. Catalent Starts Construction of USD 20M Expansion at Clinical Supply Facility in Germany
    • 14.3.14. Eurofins BioPharma Product Testing ENCO Expands the U.S. Capabilities Footprint
    • 14.3.15. Calyx Introduces New Clinical Trial Supply Forecasting Service
    • 14.3.16. Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
    • 14.3.17. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China

Companies Mentioned

  • 1. Acnos Pharma GmbH
  • 2. ADAllen Pharma Ltd
  • 3. Almac Group Limited
  • 4. Ancillare, LP
  • 5. Avantor, Inc.
  • 6. Beroe Holdings Inc.
  • 7. Biocair International Limited
  • 8. Calyx
  • 9. Catalent, Inc.
  • 10. Clinical Services International LTD
  • 11. Clinigen Group PLC
  • 12. COREX LOGISTICS LIMITED
  • 13. DHL Group
  • 14. Eurofins Scientific SE
  • 15. Experic, LLC
  • 16. FedEx Corporation
  • 17. ICON PLC
  • 18. Inceptua S.A.
  • 19. Infosys Limited
  • 20. IPS Pharma
  • 21. KLIFO A/S
  • 22. Lonza Group AG
  • 23. Marken Limited by United Parcel Service, Inc.
  • 24. Microsoft Corporation
  • 25. Myonex, Inc.
  • 26. N-SIDE SA
  • 27. NUVISAN GmbH
  • 28. OCT Clinical GmbH
  • 29. Octalsoft
  • 30. Parexel International Corporation
  • 31. PCI Pharma Services
  • 32. PHOENIX Pharmahandel GmbH & Co KG
  • 33. Piramal Pharma Limited
  • 34. Recipharm AB
  • 35. SAP SE
  • 36. Sharp Services, LLC
  • 37. Signant Health
  • 38. SIRO Clinpharm Private Limited
  • 39. Thermo Fisher Scientific Inc.
  • 40. Tower Cold Chain Solutions
  • 41. Uniphar PLC
  • 42. Walden Group
  • 43. Zuellig Pharma Pte Ltd by Interpharma Investments Limited

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 151. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 157. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 159. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 172. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 173. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 175. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 176. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 178. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 179. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 181. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 182. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 184. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 185. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 187. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 190. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 191. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 194. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 196. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 197. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 200. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 202. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 203. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 205. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 206. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 208. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 209. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 212. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 214. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 215. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 217. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 218. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 220. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 221. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 224. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 226. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 227. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 230. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 232. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 233. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 235. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 236. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 238. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 239. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 241. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 242. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 244. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 245. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 248. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 250. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 251. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 259. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 260. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 262. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 263. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 265. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 266. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 268. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 269. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 272. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 274. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 275. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 276. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 277. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 278. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 280. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 281. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 290. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 292. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 295. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023